ClinConnect ClinConnect Logo
Search / Trial NCT06315218

Examining the Health Effects of iTHRIVE 365 Among Black Same Gender Loving Men

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Mar 11, 2024

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a program called iTHRIVE 365, which is designed to help Black same-gender loving men living with HIV. The goal of this program is to improve health and well-being by offering education about HIV and mental health, creating social connections through online support groups, and providing access to healthcare services that respect their identities. The program also aims to help with practical needs, such as housing and transportation.

To participate in this study, individuals must be at least 18 years old, identify as Black or African American men, and be living with HIV while taking daily medication for their treatment. They should also have a device that connects to the internet and live in the Atlanta area. Participants can expect to engage in supportive activities and receive resources that can help improve their health and quality of life. This study is currently not recruiting participants, but it represents an important effort to address the unique challenges faced by this community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Identify as Black or African American, regardless of ethnicity
  • 2. Identify as male, regardless of sex assigned at birth
  • 3. Are living with HIV and prescribed a daily ART regimen
  • 4. Are age ≥ 18;
  • 5. Have sex with men
  • 6. Own an internet-connected device (e.g., smartphone, tablet)
  • 7. Reside in the Atlanta-area EHE jurisdictions.
  • Exclusion Criteria:
  • 1. Lack of English fluency
  • 2. Past participation in the pilot.

About Rutgers, The State University Of New Jersey

Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.

Locations

Patients applied

0 patients applied

Trial Officials

Devin English, Ph.D.

Principal Investigator

Rutgers University

Justin Smith, MS, MPH

Principal Investigator

Positive Impact Health Centers

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported